Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0014 USD | 0.00% | 0.00% | +16.67% |
Business Summary
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Novel Molecules
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | 0.00% |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | 0.00% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 86 | 12/05/82 | |
J. Finkelstein
CEO | Chief Executive Officer | 72 | 31/12/83 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
J. Finkelstein
CEO | Chief Executive Officer | 72 | 31/12/83 |
Founder | 86 | 12/05/82 | |
Joe McNay
BRD | Director/Board Member | 90 | 31/12/01 |
Mauro Bove
BRD | Director/Board Member | 69 | 31/12/03 |
R. Elsey
BRD | Director/Board Member | 71 | 31/08/10 |
Director/Board Member | 66 | 31/03/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,496,966 | 836,249 ( 55.86 %) | 0 | 55.86 % |
Company contact information
RegeneRx Biopharmaceuticals, Inc.
15245 Shady Grove Road Suite 470
20850, Rockville
+
http://www.regenerx.comSector
1st Jan change | Capi. | |
---|---|---|
+16.67% | 2.11K | |
+0.10% | 91.42B | |
+3.16% | 41.08B | |
-11.10% | 34.26B | |
+53.99% | 25.27B | |
-9.41% | 12.81B | |
-12.25% | 11.6B | |
-44.00% | 11.42B | |
+5.77% | 9.16B | |
-6.90% | 8.22B |
- Stock Market
- Equities
- RGRX Stock
- Company RegeneRx Biopharmaceuticals, Inc.